The incidence of retinopathy of prematurity (ROP) continues to rise due to the improved
survival of very low birth weight infants in developed countries. This epidemic is also fueled …

Purpose To evaluate neurodevelopmental outcomes after intravitreal bevacizumab (IVB)
therapy in retinopathy of prematurity (ROP) infants compared with those not exposed to IVB …

Background Infants with stage 3+ retinopathy of prematurity (ROP) in zone I or zone II
posterior were randomized to initial treatment with bevacizumab or laser in a multicenter trial …

Purpose To evaluate the neurodevelopmental and ocular developmental outcomes in
premature children who have undergone intravitreal bevacizumab injection (IVB) for …

Purpose To compare rates of short-term retinal detachment (RD) of infants treated for type 1
retinopathy of prematurity (ROP) with intravitreal anti–vascular endothelial growth factor …

Purpose: This study assessed the efficacy and safety of early vitamin A (VA)
supplementation to improve outcomes of retinopathy of prematurity in extremely preterm …

BACKGROUND AND OBJECTIVE: To evaluate neurodevelopmental outcomes among
infants treated for retinopathy of prematurity (ROP) at the authors' institution. PATIENTS AND …

PURPOSE To evaluate the neurodevelopmental outcomes in premature infants who
received intravitreal anti− vascular endothelial growth factor (anti-VEGF) injections to treat …

Retinopathy of prematurity (ROP) is one of the many significant consequences of premature
birth and remains one of the leading causes of visual impairment in infants. Originally …

Retinopathy of prematurity (ROP), a leading cause of childhood blindness, has historically
been associated with blindness from overgrowth of blood vessels from the retina into the …